Sat, Jul 12, 2014, 8:46 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Shire plc Message Board

  • zho10 zho10 Nov 8, 1998 7:06 AM Flag

    Galantamine takes 50% of Austrian market

    I happened accross this board by accident, and
    was surprised to see so few contributors given that
    45% of shares are now held in the US (figure correct
    at 3/98).

    I'm in the UK, and wondered if you
    had seen a news item reported here in a May edition
    of the Daily Mail newspaper. According to this,
    Galantamine (Reminyl) has been on sale in Austria since 1996
    following a small (N = 200) but promising clinical trial.
    It has already taken 50% of the market, and has
    knocked the previous leader, Pfizer's Aricept, down to
    40%. Worldwide, Aricept had sales of around �50m
    ($80m) in the last quarter, so if the Austrian situation
    were replicated world-wide this would have an enormous
    effect on SHPGY's turnover and profitability.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
249.06+10.45(+4.38%)Jul 11 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Potbelly Corporation
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT
Immersion Corporation
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT